|
2023
|
Invention
|
Method for the production of thymocyte supernatant.
Herein is reported a method for producing a ... |
|
|
Invention
|
Solid forms of a hbv core protein allosteric modifier.
Disclosed are novel solid forms of compou... |
|
|
Invention
|
Immunoassay-based determination of in-solution binding kinetics.
Herein is reported a method for... |
|
|
Invention
|
Whole slide image search.
In one embodiment, a method includes indexing a whole slide image data... |
|
|
Invention
|
Antibody that binds to vegf and il-1beta and methods of use.
The present invention relates to an... |
|
|
Invention
|
Bispecific anti-ccl2 antibodies.
The present invention relates to bispecific anti-CCL2 antibodie... |
|
|
Invention
|
Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor.
The presen... |
|
|
Invention
|
Predicting actionable mutations from digital pathology images.
A method includes accessing a dig... |
|
|
Invention
|
Compounds for treating spinal muscular atrophy.
The present invention provides compounds of form... |
|
|
Invention
|
Antibodies binding to nkg2d.
The present invention generally relates to antibodies that bind to ... |
|
|
Invention
|
Oligonucleotides for inducing paternal ube3a expression.
The present invention relates to oligon... |
|
|
Invention
|
Swallowing measurement. A diagnostic device configured to count a number of swallows of a user, t... |
|
|
Invention
|
Respiration rate measurement. Respiration rate measurement A diagnostic device configured to meas... |
|
|
Invention
|
Speech function assessment. A diagnostic device configured to assess the speech function of a sub... |
|
|
Invention
|
Assessment of lung capacity, respiratory function, abdominal strength and/or thoracic strength or... |
|
|
Invention
|
Protease-activated polypeptides. The present invention generally relates to novel protease-activa... |
|
|
Invention
|
Improved protease-activatable t cell bispecific antibodies. e.g.e.g., in the treatment of disease. |
|
|
Invention
|
Supply chain optimization with reinforcement learning. The present invention relates to systems a... |
|
|
Invention
|
Fluorescent probes for magl. The invention provides compounds having the general formula (I) or (... |
|
|
Invention
|
Positive control system and method for validating positive control of container closure integrity... |
|
|
Invention
|
A multidimensional lc system for analysing antibodies.. The invention related to a multidimension... |
|
|
Invention
|
Method for separating full and empty aav particles. Herein is reported a method for separating fu... |
|
|
Invention
|
Novel phagocytosis assay combining a synthetic cell death switch and a phagocytosis reporter syst... |
|
|
Invention
|
Inspection system and method for a closed medical container. An inspection system (1.3) is operat... |
|
|
Invention
|
T cell receptor identification. The present disclosure relates to the fields of molecular biology... |
|
|
Invention
|
Double-stranded rna molecule for administration to the eye. The present invention relates to doub... |
|
|
Invention
|
Packaging member for a photosensitive drug substance. The present invention is directed to a pack... |
|
|
Invention
|
Recombinant t cell receptors. The present disclosure relates to the fields of molecular biology, ... |
|
|
Invention
|
Prediction of pharmacokinetic properties of chemical compounds. Prediction of pharmacokinetic pro... |
|
|
Invention
|
Synthetic time-series data generation and its use in survival analysis and selection of frug for ... |
|
|
Invention
|
Novel biomarkers and uses thereof.
Disclosed herein are novel biomarkers for identifying patient... |
|
|
Invention
|
Dosage regimen of vicasinabin. -tert-tert-butyl-3-[(1-methyltetrazol-5- yl)methyl]triazolo[4,5-d]... |
|
|
Invention
|
Anti-cb2 antibodies and their use in a flow cytometry assay to measure cell surface cb2 expressio... |
|
|
Invention
|
Bispecific antigen binding molecules targeting ox40 and fap.
The invention relates to novel bisp... |
|
|
Invention
|
Novel synthesis of phosphorodithioate oligonucleotides.
The invention provides the use of a comp... |
|
|
Invention
|
Threose nucleic acid antisense oligonucleotides and methods thereof. Described are antisense olig... |
|
|
Invention
|
Novel deuterated pyrimidin-2-yl sulfonamide derivatives. The invention relates to novel compounds... |
|
|
Invention
|
Process for the de-tritylation of oligonucleotides.
The invention relates to a novel process for... |
|
|
Invention
|
Combination therapy of anti-cd20/anti-cd3 bispecific antibodies and 4-1bb (cd137) agonists.
The ... |
|
|
Invention
|
In vitro glycoengineering of antibodies.
Herein is reported a method for producing an antibody c... |
|
|
Invention
|
Antibodies binding to gprc5d.
The present invention generally relates to antibodies that bind to... |
|
|
Invention
|
Attention-based multiple instance learning.
Systems and methods relate to predicting disease pro... |
|
|
Invention
|
Combination therapy of pd-1 axis binding antagonists and lrrk2 inhitibors.
The present invention... |
|
|
Invention
|
Artificial vitreous humor for the investigation of drugs and drug formulations.
The invention re... |
|
|
Invention
|
Spr-based bridging assay format for determining the biological activity of multivalent, multispec... |
|
2022
|
Invention
|
Combination therapy of pd-1-targeted il-2 variant immunoconjugates and fap/4-1bb binding molecule... |
|
|
G/S
|
Online-information services, namely, providing on-line information about accessing computer netwo... |
|
|
Invention
|
Split antibodies which bind to cancer cells and target radionuclides to said cells.
The present ... |
|
2021
|
Invention
|
Ph-dependent mutant interleukin-2 polypeptides.
The present invention generally relates to pH-de... |
|
2020
|
Invention
|
Artificial transmembrane proteins for detecting intracellular or intravesicular biomolecular inte... |
|
2019
|
G/S
|
Medical and scientific research in the field of diabetes; Consultation pertaining to pharmacology... |
|
2017
|
G/S
|
laboratory instruments, namely, clinical chemistry analyzers and immunochemistry analyzers for th... |
|
|
G/S
|
a full line of in vitro diagnostic agent, namely, reagents, control solutions for calibrating and... |
|
|
G/S
|
medical diagnostic test strips for determining the level of glucose in blood for medical and clin... |
|
|
G/S
|
blood glucose monitors for medical purposes, lancet devices, lancets; insulin delivery devices an... |
|
2008
|
G/S
|
full line of pharmaceutical preparations |
|
|
G/S
|
pharmaceutical antiviral preparation |
|
2000
|
G/S
|
[ Chemical products, namely, diagnostic preparations for scientific or medical research use; cont... |
|
1999
|
G/S
|
providing information about a pharmaceutical company and its products and services via a web site... |
|
1997
|
G/S
|
pharmaceutical preparation, namely, an anticancer drug |
|
1994
|
G/S
|
pharmaceutical preparation; namely, an antiviral |
|
1993
|
G/S
|
pharmaceutical preparation, namely an immunosuppressive agent |
|
1985
|
G/S
|
COMPUTERS AND ELECTRONIC LABORATORY TESTING APPARATUS USED FOR ANALYSIS OF BIOLOGICAL FLUIDS, PHA... |
|
1984
|
G/S
|
Clinical Laboratory Services |
|
1982
|
G/S
|
Antibiotic Preparation |
|
1977
|
G/S
|
[ PROVIDING COMPUTER SCORED PSYCHIATRIC AND PSYCHOLOGICAL TESTING SERVICES; ] PROVIDING PHARMACEU... |
|
|
G/S
|
MEDICAL BOOKLETS AND PAMPHLETS |
|
|
G/S
|
PHARMACEUTICAL PREPARATIONS FOR HUMAN [AND VETERINARY] USE |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS[; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE C... |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS [ ; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE... |
|
1949
|
G/S
|
[ AGENTS USED IN ALLERGY, ANALGESICS, ANALEPTICS, ] ANTI-INFECTIVES [, ANTISPASMODICS ANESTHETIC... |
|
1897
|
G/S
|
CHEMICAL PRODUCTS FOR USE IN MEDICINE AND PHARMACY [ , DISINFECTANTS, AND PERFUMES ] |
